AI-generated summary
The authors report a crossover randomized placebo-controlled pilot study of 22 Parkinson's disease patients who received one month of bright light therapy or dim light therapy, with vestibular-evoked myogenic potential measurements before and after each. Excessive daytime sleepiness, anxiety, quality of life and autonomic function improved after bright light therapy, but the difference compared with dim light therapy was not significant. Some VEMP peak latencies changed significantly, which the authors suggest may indicate improved brainstem function.
- Participants
- 22
- Who or what was studied
- Patients with Parkinson's disease
- Limits stated in the abstract
- The abstract describes a small pilot study, and the clinical symptom differences compared with dim light therapy were not significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Pilot study, Placebo-controlled, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.